News & Updates

Show Multimedia Only

Multiple moles, genetic predisposition up risk of second primary melanomas

22 Jan 2023

Individuals with multiple nevi and high genetic predisposition to melanoma appear to have the highest risks of developing second primary melanomas, according to a study.

22 Jan 2023

Lebrikizumab–topical corticosteroid combo improves outcomes in moderate-to-severe AD

16 Jan 2023 by

Treatment with lebrikizumab, when combined with low- to mid-potency topical corticosteroid (TCS), helps reduce disease severity in adolescent and adult patients with moderate-to-severe atopic dermatitis (AD), with a safety profile consistent with that reported in previous AD studies, according to the phase III ADhere trial.

16 Jan 2023

Obesity reduces adalimumab potency against hidradenitis suppurativa

14 Jan 2023

Adalimumab for the treatment of hidradenitis suppurativa appears to be less effective in patients with obesity, a study has found.

14 Jan 2023

JAK inhibitors pose increased risk of developing shingles

12 Jan 2023

Exposure to the Janus kinase (JAK) inhibitors tofacitinib and upadacitinib, as well as to JAK inhibitors as a class, appears to put individuals at increased risk of developing herpes zoster infection, with the risk increasing at higher doses, as reported in a study.

12 Jan 2023

Tralokinumab improves skin microbial dysbiosis in atopic dermatitis

10 Dec 2022

In patients with atopic dermatitis (AD), treatment with the IL-13 cytokine-targeting tralokinumab appears to directly or indirectly improves skin microbial dysbiosis, reports a new trial.

10 Dec 2022

Rituximab yields cardiometabolic protection in pemphigus patients

09 Dec 2022

Treatment with rituximab appears to confer protective effects against long-term cardiovascular and metabolic outcomes in patients with pemphigus as compared with conventional immunosuppressants, according to a study.

09 Dec 2022

Exposure to air pollution ups risk of atopic dermatitis

07 Dec 2022

Long-term exposure to air pollutants, including gases and particulate matter, may increase the risk of developing atopic dermatitis (AD), according to a recent study.

07 Dec 2022

Cyclosporin may increase malignancy risk in psoriasis

07 Dec 2022

In psoriasis patients, treatment with cyclosporin may increase the risk of malignancy without nonmelanoma skin cancer, a recent study has found. Biologic or phototherapy have no such impact.

07 Dec 2022

Laser superior to cryotherapy for hard-to-treat warts

06 Dec 2022

Use of long-pulsed neodymium-doped yttrium-aluminium-garnet (LP-Nd:YAG) laser provides similar overall therapeutic effects to those of cryotherapy, results of a recent study have shown. However, laser appears more effective against recalcitrant warts and results in shorter time to warts clearance.

06 Dec 2022

Itraconazole effective for ringworm of the body but requires longer treatment

06 Dec 2022

Itraconazole appears to be effective in the treatment of patients with tinea corporis/cruris (TCC) or ringworm of the body, as shown in a study. However, the treatment duration needs to be longer and, even with successful treatment, many patients experience relapse.

06 Dec 2022

News & Updates

Showing Dermatology articles

Showing

Specialty:

Multiple moles, genetic predisposition up risk of second primary melanomas

Lebrikizumab–topical corticosteroid combo improves outcomes in moderate-to-severe AD

Obesity reduces adalimumab potency against hidradenitis suppurativa

JAK inhibitors pose increased risk of developing shingles

Tralokinumab improves skin microbial dysbiosis in atopic dermatitis

Rituximab yields cardiometabolic protection in pemphigus patients

Exposure to air pollution ups risk of atopic dermatitis

Cyclosporin may increase malignancy risk in psoriasis

Laser superior to cryotherapy for hard-to-treat warts

Itraconazole effective for ringworm of the body but requires longer treatment